Suppr超能文献

mRNA 平台在 SARS-CoV-2 疫苗方面的积极方面。

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.

机构信息

Department of Medical Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.

Department of Zoology, Faculty of Science and Technology, Omdurman Islamic University, Omdurman, Sudan.

出版信息

Hum Vaccin Immunother. 2021 Aug 3;17(8):2445-2447. doi: 10.1080/21645515.2021.1900713. Epub 2021 Apr 8.

Abstract

The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID-19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA-based COVID-19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID-19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID-19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination.

摘要

为了长期控制 2019 年冠状病毒病(COVID-19),现在前所未有地需要获得一种安全有效的疫苗,这是一项全球性的迫切需求。研究人员一直在紧急和协作地开发针对 COVID-19 病原体的疫苗。信使 RNA(mRNA)疫苗平台的使用为开发有效疫苗提供了新的机会。首次在临床试验之外的个体中使用 COVID-19 mRNA 疫苗引起了人们对其安全性和未来疗效的担忧。在社交媒体上,特别是在发展中国家,广泛传播的虚假说法声称,目前基于 mRNA 的 COVID-19 疫苗可能整合到宿主基因组中,从而可能对人类进行基因修饰。这些疫苗也被认为由于新菌株的出现而缺乏疗效。这些错误信息导致人们对接种 COVID-19 疫苗犹豫不决。本评论旨在概述 COVID-19 mRNA 疫苗的结构、作用机制和主要用途,重点是从科学角度解决与阴谋论相关的挑战,并消除围绕疫苗接种的错误信息。

相似文献

1
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.
Hum Vaccin Immunother. 2021 Aug 3;17(8):2445-2447. doi: 10.1080/21645515.2021.1900713. Epub 2021 Apr 8.
2
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
3
SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
Immunol Invest. 2021 Oct;50(7):802-809. doi: 10.1080/08820139.2021.1936009. Epub 2021 Jun 10.
5
Network Analysis of COVID-19 Vaccine Misinformation on Social Media.
Stud Health Technol Inform. 2021 Nov 18;287:165-166. doi: 10.3233/SHTI210839.
6
mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Annu Rev Med. 2022 Jan 27;73:17-39. doi: 10.1146/annurev-med-042420-112725. Epub 2021 Oct 20.
7
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
Expert Rev Vaccines. 2022 Sep;21(9):1177-1184. doi: 10.1080/14760584.2022.2089120. Epub 2022 Jul 1.
9
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
10
The global COVID-19 vaccine surplus: tackling expiring stockpiles.
Infect Dis Poverty. 2023 Mar 20;12(1):21. doi: 10.1186/s40249-023-01070-7.

引用本文的文献

1
Attitudes and acceptance of mRNA-based vaccine for neglected tropical diseases: A multi-country study in Asia.
Hum Vaccin Immunother. 2025 Dec;21(1):2526231. doi: 10.1080/21645515.2025.2526231. Epub 2025 Jul 1.
2
The Application of mRNA Technology for Vaccine Production-Current State of Knowledge.
Vaccines (Basel). 2025 Apr 4;13(4):389. doi: 10.3390/vaccines13040389.
3
Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023).
Hum Vaccin Immunother. 2023 Dec 15;19(3):2276624. doi: 10.1080/21645515.2023.2276624. Epub 2023 Nov 14.
5
Protective RNA nanovaccines against subspecies .
Front Immunol. 2023 Jun 8;14:1188754. doi: 10.3389/fimmu.2023.1188754. eCollection 2023.
7
mRNA vaccines in the prevention and treatment of diseases.
MedComm (2020). 2022 Aug 25;3(3):e167. doi: 10.1002/mco2.167. eCollection 2022 Sep.
8
COVID-19 vaccine misinformation in English-language news media: retrospective cohort study.
BMJ Open. 2022 Jun 1;12(6):e058956. doi: 10.1136/bmjopen-2021-058956.
9
COVID-19: Main findings after a year and half of unease and the proper scientific progress (Review).
Exp Ther Med. 2022 Jun;23(6):424. doi: 10.3892/etm.2022.11350. Epub 2022 May 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验